Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/424
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWalton, Anthony-
dc.contributor.otherManoharan, Ganesh-
dc.contributor.otherBrecker, Stephen-
dc.contributor.otherPasupati, Sanjeevan-
dc.contributor.otherBlackman, Daniel-
dc.contributor.otherQiao, Hongyan-
dc.contributor.otherMeredith, Ian-
dc.date.accessioned2015-10-08T05:58:23Z-
dc.date.available2015-10-08T05:58:23Z-
dc.date.issued2015-08-
dc.identifier.citationJACC Cardiovasc Interv. 2015 Aug 24;8(10):1359-67en_US
dc.identifier.issn1936-8798en_US
dc.identifier.urihttp://hdl.handle.net/11434/424-
dc.description.abstractOBJECTIVES: The purpose of this study was to prospectively evaluate the safety and clinical performance of the CoreValve Evolut R transcatheter aortic valve replacement (TAVR) system (Medtronic, Inc., Minneapolis, Minnesota) in a single-arm, multicenter pivotal study in high- or extreme-risk patients with symptomatic aortic valve stenosis. BACKGROUND: Although outcomes following TAVR are improving, challenges still exist. The repositionable 14-F equivalent CoreValve Evolut R TAVR system was developed to mitigate some of these challenges.en_US
dc.publisherScience Directen_US
dc.subjectVictorian Heart Centre, Epworth HealthCare, Melbourne, Australia.en_US
dc.subjectCardiologyen_US
dc.subjectCardiac Servicesen_US
dc.subjectHeart Surgeryen_US
dc.subjectCardiac Surgeryen_US
dc.subjectAortic Valve Stenosisen_US
dc.subjectSelf-expanding Heart Valveen_US
dc.subjectTranscatheter Aortic Valve Replacementen_US
dc.subjectSymptomatic Severe Aortic Stenosisen_US
dc.titleTreatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System.en_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1016/j.jcin.2015.05.015en_US
dc.identifier.journaltitleJACC. Cardiovascular Interventionsen_US
dc.description.pubmedurihttp://www.ncbi.nlm.nih.gov/pubmed/26315740en_US
dc.description.affiliatesRegional Cardiology Department, Royal Victoria Hospital, Belfast, United Kingdomen_US
dc.description.affiliatesCardiology and Interventional Cardiology Services, St. George's Hospital, London, United Kingdomen_US
dc.description.affiliatesDepartment of Cardiology, Waikato Hospital, Hamilton, New Zealanden_US
dc.description.affiliatesDepartment of Cardiology, Leeds General Infirmary, Leeds, United Kingdomen_US
dc.description.affiliatesStatistical Services, Medtronic, Inc., Minneapolis, Minnesotaen_US
dc.description.affiliatesDepartment of Medicine, Monash University, Melbourne, Australiaen_US
dc.description.affiliatesMonash Health, Melbourne, Australiaen_US
dc.description.affiliatesMonashHEART, Melbourne, Australiaen_US
dc.description.affiliatesMonash Cardiovascular Research Centre, Melbourne, Australiaen_US
dc.type.studyortrialProspective Cohort Studyen_US
dc.type.contenttypeTexten_US
Appears in Collections:Cardiac Sciences

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.